Building a foundation to advance clinical trial processes through UK focused innovation admits dynamic regulatory and political environment
|
|
- Claud Holt
- 6 years ago
- Views:
Transcription
1 Building a foundation to advance clinical trial processes through UK focused innovation admits dynamic regulatory and political environment The 5 th Annual Outsourcing in Clinical Trials UK & Ireland 2018 conference is back after a successful 2017 to help build business strategy through the changing regulatory and political climate. This event is part of a global series aimed at tackling the vital concerns presently taxing the UK and Ireland Pharmaceuticals sector in this varied and evolving commercial area. Confirmed 2018 Speakers Tim Cave, VP - Head Strategic Planning and Digital Practices, Global Medical Affairs, GSK Lucy Clossick Thomson, Director Clinical Operations Strategy, Early Clinical Development, AstraZeneca John Shillingford, CEO, Orsus Medical Chris Holland, Director, Clinical Documentation Operations, GSK Andrew Thompson, Director of Therapy Research and Analysis, Medical Devices, GlobalData Health Tianbo Xu, Co- author & Research Associate, UCL Institute of Neurology George Morris, COO, ValiRx Diane Driver, Head Outsourcing Contracts & Strategic Partnerships, UCB Tone Bjaaland, Director- Head of Clinical Operations, PrEP Biopharm Tanja Ouimet, Head of Clinical Operations, Pharma Leads Trishna Bharadia, Patient Advocate Dr Yuri Martina, VP- Clinical Operations, Grünenthal GmbH Ian Hodgson, Head of Clinical Operations, Mereo BioPharma Tina Harris, Director, Data Management, Amgen Dr Panos Georgiou, Senior Clinical Scientist, Indivior Pharma Belle Roels, Head of Clinical Operations UK and Ireland, GSK Alan Palmer, Non- Executive Director, One Nucleus 2018 Event Sponsors
2 Outsourcing in Clinical Trials, UK & Ireland Programme Day One Tuesday 12 th June, :45 Registration and refreshments 08:20 Chair s opening remarks 08:30 Keynote It s A Digital World! Making Technology The Foundation Of Clinical Trial Advancement The future of clinical trials requires a more streamlined, connected and more engaged with the patient. For pharmaceuticals to embrace these requirements, the adoption of new digital tools will be vital. Clinical trials are becoming increasingly complex with growing amounts of data being collected, thus better approaches are needed, applying the current systems and technology better to meet these new age challenges. Analysing the new GSK business model to evaluate the various ways to leverage digital platforms to create seamless trial operations Practicing targeted and influential engagement with HCPs & patients to boost sales and marketing by optimising new technologies and trends Highlighting various digital technology in clinical trials to promote integration & innovation of digital strategy for long-term success Communicating clinical trial evidence through digital tools avenues for transparency Tim Cave, VP - Head Strategic Planning and Digital Practices, Global Medical Affairs, GSK 09:00 Session reserved for UBC 09:30 Case Study Reviewing Your Request For Information (RFI) & Request For Proposal (RFP) To Ensure Long Term Business Objectives Are Met Case study analysis into the pertinent questions surrounding the composition RFI and RFP documents to ensure clarity between the supplier and sponsor Clarifying who is responsible when creating the RFI to ensure transparency Incorporating a scoring framework to evaluate the RFI & RFP so that business aims can be reviewed Creating the right RFI to identify lower cost alternatives and reductions Assessing the tools needed to make the final decision on your service provider Lucy Clossick Thomson, Director Clinical Operations Strategy, Early Clinical Development, AstraZeneca 10:00 Session available to sponsor
3 10:30 From Print To Speech; Improving clinical trials with machine learning Revitalising the way you view clinical trials to make sure the best environment is created to conduct your trials. Appreciating the complexities of human beings and reflecting this accurately in trials through the use of machine learning instead of archaic statistical techniques to achieve the most accurate study results Highlighting the positive cost implications in using machine learning to conduct your clinical trials to formalise complex decisions and to detect drug side- effects that are typically missed Outlining how the UK public health infrastructure is complimentary for the large amounts of data needed when applying machine learning Recognising the need to upgrade legacy technology systems with new machine learning tools to get the best data Driving your workforce to engage with new technology to push trial innovation Tianbo Xu, Co- author & Research Associate, UCL Institute of Neurology 11:00 Morning Break and Refreshments 11:30 Likes & Pokes As The Tool To An Effective Patient Recruitment Strategy This panel session will explore the use of digital platforms, debunking the myth that digital platforms have demographic, cost and compliance restrictions to strengthen the bridge between the patients and clinical trials. Unlocking social media platforms such as Facebook and Instagram as a pre-screening tool to save time during patient recruitment Tackling the potential compliance and confidentiality issues surrounding the use of social media to recruit patients whilst adhering to best practice Saving money on lengthy recruitment processes through cost effective digital advertising strategies Engaging the extensive network of patient advocacy groups based online by using their social media platforms to advertise your trial Tanja Ouimet, Head of Clinical Operations, Pharma Leads 12:00 Retain Retain Retain Effectively Engaging Patients To Ensure Trial Completion An ineffective enrolment strategy can have huge ramifications on a study, with delays costing sponsors on average over 32K in operational costs and up to 7M in lost opportunity costs. How can your study remain attractive for patients? Planning patient led trials, ensuring maximum retention rates throughout your study to ensure timelines are met Securing the retention of your participants from a distance by designing the right remote monitoring framework
4 Recognising the positive impact of creating strong links with patient advocacy groups on your trial to help generate a more suitable pool of patient candidates Ian Hodgson, Head of Clinical Operations, Mereo BioPharma 12:30 Workshop Patients Taking The Lead, Designing The Right Study Patient recruitment is still one of the most difficult challenges when conducting trials. This patient-led interactive workshop endeavours to provide you with the much needed patient lens to ensure you are constructing patient-focused studies. Mini case study and presentation on a patients journey through a clinical trial Discussing challenges and benefits for patient incorporation when designing your study Gather in small teams to create the right study for your patient using the tools from the presentation Present your study and highlight the key study components that make it attractive to patients Trishna Bharadia, Patient Advocate 13:15 Lunch and Networking 14:15 Site Roulette- Selecting The Best Facilities For Trial Harmonisation 60% of clinical trials do not enlist participants within the initially forecasted timelines, and typically between 20-30% of selected sites fail to recruit patients. As an integral part of the whole clinical trial experience it is necessary that there are verified and reliable frameworks used to select trial sites. Designing a suitable feasibility study for your trial so that you select a site that can deal with the capacity of your trial Recognising the complexity of feasibility studies as a multi- dialogue feedback platform in potentially adapting the overall structure of the trial to create a holistic study Establishing the capability of a site through strong partnership between the sponsor and vendor to ensure trial goals are met Incorporating feedback and information from all study stakeholders alongside additional data to reach optimal site selection Dr Panos Georgiou, Senior Clinical Scientist, Indivior Pharma 14:45 Session available to sponsor 15:15 Small And Mighty; Managing Vendors With Little Resources To Guarantee Your Objectives Are Achieved
5 The industry is under increased pressure to innovate to reflect the changing environment in which it operates. Thus more products are being developed and companies are working with more stakeholders particularly vendors to cope with the increasing products developed. This is opportunity to discuss ways to manage vendors with restricted resources. Sharing case studies of managing vendors during large studies with a limited budget and resources Maximising your company assets to make your business attractive to vendor partnerships Maintaining your budget and timeline goals by improving trial forecasting capabilities with your vendors Analysing the best framework to oversee vendors with limited time and staff to achieve all clinical trial objectives Tone Bjaaland, Director- Head of Clinical Operations, PrEP Biopharm 15:45 Case Study Putting The Theory To Action; The Little Guys Managing The Big Guys With the UK & Irish market being saturated with small pharmaceuticals and biotech s it is helpfully to strategise together to ensure you are managing your CRO for competitive advantage. Discussing specific case studies to illustrate best practice when managing multiple vendors as a smaller company Ensuring a detailed and explicit contract between stakeholders to ascertain areas for renegotiations of objectives to create potential cost savings Demonstration of creating transparency throughout vendor negotiations to make sure objectives are scalable and achievable Creating cost savings without compromising the integrity and timescale of your trial John Shillingford, CEO, Orsus Medical 16:15 Afternoon Refreshments and Networking 16:45 Regulatory Update Keeping Everything Private- Obeying The Data Privacy Laws For Regulatory Transparency As the General Data Protection Regulation (GDPR) is enforced, there will be increased accountability for all parties involved in handling and producing data, which is central to the way clinical trials are conducted. Stay ahead of the regulatory curve. Discussing your data handling methods to ensure compliance with the EU General Data Protection Regulation (GDPR) Addressing the best data storage framework to preserve your clinical data Designing your study to reflect the data privacy changes to avoid regulatory discrepancies Preserving the balance between the big data boom and patient confidentiality Selecting the right data protection officer to manage the extra regulatory responsibility
6 Tina Harris, Director, Data Management, Amgen 17:15 Managing Your Trial Master File To Uphold The Integrity Of Your Product Given the new guidelines put in place to assist sponsors and investigators with clinical trial master file (TMF) requirements, how can we improve the total oversight process to stay compliant with TMF requirements? Evaluating ways to streamline TMF management to create a strong repository for trial compliance Discussing the multiple outsourcing options within this area to ensure you have the right partnership to manage your documents Highlighting the advantages of using an electronic trial master file system when conducting global trials, such as ease of access and traceability Considering the Regulation [(EU) No 536/2014] and ICH-GCP E6 as foundation to developing a TMF that adequately facilitates trial management Chris Holland, Director, Clinical Documentation Operations, GSK 17:45 Chair s Summary & Closing Close of Day One Outsourcing in Clinical Trials, UK & Ireland Programme Day Two Wednesday 13 th June, :30 Registration and Refreshments 08: Chair s Opening Remarks Speaker Hosted Roundtables Interactive roundtable sessions offer a unique opportunity to come together with your peers to share best practice and develop solutions to critical challenges facing the industry as a whole. Each roundtable session lasts for 45 minutes. Roundtable 1 Roundtable 2 Roundtable 3 Roundtable 4 Delegates may select the most relevant roundtable discussion to their area of interest. All roundtable findings will be collated by your host, and shared post-event. Retain Retain Retain Effectively Engaging Patients To Ensure Trial Completion Belle Roels, Head of Clinical Operations UK and Ireland, GSK Creating The Optimal Vendor Selecting And Oversight Process Exploring The Avenues For Innovation post- Brexit Assessing The Necessary Requirements To Create A Suitable Protocol
7 10:30 Morning Refreshments and Networking 11:00 Case Study Partnerships Made Of Iron... Building Long Lasting Relationships For Seamless Study Execution A case study session which touches on tangible indicators used to create strong sponsor-vendor relationships through exploring a variety of outsourcing models, their advantages and fundamental points to consider. Exploring the best ways to create a healthy and mutually beneficial relationship between vendors and sponsors for trial harmonisation Pairing your study with the appropriate outsourcing model to get the most out of the vendorsupplier partnership A focused look at full service and functional outsourcing models to establish the most cost effective framework Negotiating suitable key performance indicators to ensure your master service agreement will lead to a harmonised vision of the study for successful trial completion Diane Driver, Head Outsourcing Contracts & Strategic Partnerships, UCB 11:30 The Birds Eye View: Defining Strategy To Maintain Vendor Oversight This session aims to explore the various frameworks and actors that can be applied or considered when overseeing vendors, to ensure there are clear responsibilities when undertaking any clinical trial so all aspects of the trial are executed effectively. Devising an effective oversight plan to maintain GCP throughout your trial to promote role transparency and successful completion of clinical trials Adhering to the ICH GCP R2 guideline to maintain sponsor oversight that fits within the regulatory guidelines so studies remain compliant Giving the CRO the necessary autonomy while fulfilling your oversight requirements to ensure trial harmonisation and unified trial objectives Implementing the right oversight framework when managing global trials to maintain transparent communication for smooth completion of your study George Morris, COO, ValiRx 12:00 What Does The Future Hold? Developing The Best Framework For Central Nervous System (CNS) Trials Due to the complexity of CNS products companies tend to face many obstacles in improving trial methods and quality to optimise products life cycles particularly because CNS trials are more expensive timeconsuming than other trials, they re also less likely to be successful and gain approval. With therapies for CNS-related disorders representing 21% of the total pharmaceutical marketplace but only 8% of CNS drugs making it through clinical trials, it s clear that a well-executed CNS clinical trial can be extremely
8 profitable for a company. Preparing for CNS clinical trials by highlighting new trends and technologies in CNS product development Selecting the right site and other key stakeholders to improve your chances of successful trial Designing the most appropriate trial design to alleviate the burden on sites and patients participating in trials to ensure trial success Analysing the use of computerized approaches to gain more targeted data for your trial Alan Palmer, Non- Executive Director, One Nucleus 12:30 Networking Lunch 13:30 Exploring Clinical Trials With Advanced Therapeutic Medicinal Products (ATMP) Novel areas of therapy research are spawning an increasing variety of cell based, tissue engineered or gene modifying approaches for the treatment/prevention of disease. Companies conducting clinical trials with these products may encounter a variety of issues during development; this presentation considers the issues likely to be encountered and discusses ways to proactively address these Discussing the potential for ATMP s in a post- Brexit environment where innovative therapy may become increasingly important in maturing an independent UK clinical market Highlighting vital regulatory considerations when considering ATMP s to remain compliant in a dynamic, complex and rapidly advancing area Addressing operational challenges when conducting ATMP trials to avoid unsuccessful trials and incomplete products Exploring the expansive nature of ATMP s to expand your company s product capabilities 14:00 Discussing The role Of Companion Diagnostic Testing In Saving Costs This session is an insightful beginning into the partnership between medical device and pharmaceuticals in creating drugs with a personalised application to optimise its effect and save costs. Highlighting the collaboration between medical device and drug development companies to spark continuous innovation in this space Exploring key characteristics for the various specialised vendors who provide the niche tests for companion diagnostic tests to ensure you have suitable partnership for your trial Appreciating the role of companion diagnostic testing in solidifying the cost of your products to buyers through its ability to identify patients likely to benefit from a therapeutic product Emphasising the importance of this testing to make certain the right patients are signed up for your trial to mitigate any post approval study issues Andrew Thompson, Director of Therapy Research and Analysis, Medical Devices, GlobalData Health
9 14:30 Afternoon Break and Networking 15:00 Regulatory Update Compliance Is Key- Unlocking The ICH GCFP R2 Regulation To Improve Trial Performance Good Clinical Practice is at the foundation of all aspects of the trial process. Most major and critical findings are observed at Clinical Investigator, Sponsor, and CRO sites. Furthermore, the sponsor and the CRO accounts for nearly 43% of the total findings it is important to stay up to date with the evolving regulatory requirements for clinical trials to discuss the likely impacts and challenges they pose for current and future trials. Addressing the difference between the R1 and R2 version of the ICH guideline to ensure full compliance across all trials Exploring the amended oversight responsibilities for the sponsor for any outsourced work to ensure the integrity of the study tasks performed and any data generated Explaining the relevance for sponsors to have original written procedures in place for all electronic systems used during trials to uphold the integrity of the data collected Dr Yuri Martina, VP- Clinical Operations, Grünenthal GmbH 15:30 Live Debate This House Believes that Brexit Will Stimulate Clinical Trial Innovation in the UK 16:15 Moderator Opening Remarks Knocking On 10 Downing Street Preparing A Future Ready Plan - How can the UK remain positive? Let s discuss innovation, business adaptation and focus on bringing the UK industry at the forefront of the clinical market! 16:20 Initial Audience Vote 16:25 Arguments For 16:30 Arguments Against 16:35 Interactive Debate/Q&A 16:55 Final Audience Vote Discussing the advantages of Brexit in pushing drug innovation within the UK clinical market Highlighting the strength of the UK clinical industry to appeal to investors, ensuring future global collaborations Evaluating the regulatory impact of Brexit on current business structure to plan for the future Ensuring continued trial compliance by applying the right post- Brexit strategy 16:15 Chair s Summary & Closing Close of Conference
10
Outsourcing in Clinical Trials West Coast: Medical Device Stream Burlingame, CA February 22 nd 2018
Outsourcing in Clinical Trials West Coast: Medical Device Stream Burlingame, CA February 22 nd 2018 Speakers Confirmed: Lian Cunningham, Vice President, Clinical Affairs and Regulatory Affairs, BAROnova
More informationDRAFT DOCUMENT FINAL COPY TO REFLECT CONFIRMED. Embed Innovations to Transform Your R&D Procurement Model and. Drive Scientific Activities Efficiency
Embed Innovations to Transform Your R&D Procurement Model and Drive Scientific Activities Efficiency April 30 May 1, 2018 Boston, US This conference exceeded all of my expectations. The topics, speakers
More informationBEST PRACTICES GUIDE COMPLYING WITH THE ICH E6(R2) ADDENDUM
BEST PRACTICES GUIDE COMPLYING WITH THE ICH E6(R2) ADDENDUM Six steps to ensuring risk-based quality management in clinical trials EVOLVING REGULATIONS ON RISK-BASED MONITORING In 2016, the International
More informationCLINICAL TRIALS SUPPLY NEW ENGLAND
CLINICAL TRIALS SUPPLY NEW ENGLAND 26 TH -27 TH MARCH BOSTON, MASSACHUSSETS Developing best practices and incorporating novel technologies to meet the demands of a more complex, international clinical
More information2018 Confirmed Speakers
The leading clinical trial supply series delivering localised content to key biopharma clusters 2018 Confirmed Speakers Eyal Ron, Chief Technology Officer, Gelesis Michael Sparozic, Trial Supplies Operation
More informationMeeting sponsor s criteria : strategy to collaborate, engage and deliver
Meeting sponsor s criteria : strategy to collaborate, engage and deliver Frédérique Couttet Clinical Trial Manager 4th Annual Outsourcing in Clinical Trials Europe Brussels, Switzerland, May 21 22, 2014
More informationOutsourcing in Clinical Trials 2017 Day One May Programme Day One
Outsourcing in Clinical Trials 2017 Day One May 23 2017 Programme Day One 7:50 Registration and refreshments 8:20 Chairman s opening remarks 8:30 Opening Keynote: Developing lean models for outsourcing
More information10:00 Examining the Challenges with Sourcing the Right CRO and Vendors for Global Trials
Outsourcing in Clinical Trials East Asia 6 th December 2017 Program Day One 08:30 Registration and Refreshments 08:50 Chair s Opening Speech 09:00 The Key Elements to Success: Learning about the Essential
More informationOUTSOURCING IN CLINICAL TRIALS SOUTH EAST
OUTSOURCING IN CLINICAL TRIALS SOUTH EAST March 13 th -14 th, 2018 I Durham, North Carolina, USA 2018 Speaking Faculty Nicole Leedom, Director Clinical Operations, SpringWorks Therapeutics William Gluck,
More informationCLINICAL TRIALS SUPPLY NEW ENGLAND
CLINICAL TRIALS SUPPLY NEW ENGLAND 26 TH -27 TH MARCH BOSTON, MASSACHUSSETS Developing best practices and incorporating novel technologies to meet the demands of a more complex, international clinical
More informationOutsourcing in Clinical Trials East Coast 2017 King of Prussia, PA, May
Outsourcing in Clinical Trials East Coast 2017 King of Prussia, PA, May 23-24 2017 Outsourcing in Clinical Trials East Coast brings together the clinical operations and outsourcing community from pharma,
More information2019 Speakers Confirmed:
2019 Speakers Confirmed: Sharon Goldfarb, VP Regulatory & Clinical, GI View Avraham Biran, Director Clinical, Regulatory & Quality, BlueWind Medical Tsvia Erlich, VP Regulatory & Clinical Affairs, ConTIPI
More information2019 Speakers Confirmed:
2019 Speakers Confirmed: Sharon Goldfarb, VP Regulatory & Clinical, GI View Avraham Biran, Director Clinical, Regulatory & Quality, BlueWind Medical Tsvia Erlich, VP Regulatory & Clinical Affairs, ConTIPI
More informationOutsourcing in Clinical Trials Southern California 2017 September 27 th 28 th La Jolla, California
Outsourcing in Clinical Trials Southern California 2017 September 27 th 28 th La Jolla, California 2017 Speaking Faculty Larn Hwang, CSO, Autotelic Inc Mathias Schmidt, CEO, ArmaGen Dr. Vlad Bogin, CEO,
More informationAbout Arena s Clinical Trial Series Confirmed Speaking Faculty
About Arena s Clinical Trial Series The Clinical Trials Conference series launched over a decade ago and now runs in more than 14 locations worldwide. The acclaimed series is a platform for biopharmaceutical
More informationTestimonials from OCT Attendees: 2018 Speakers Include:
Exploring innovative strategies in clinical outsourcing and operations to optimise trial outcomes Testimonials from OCT Attendees: At OCT, I greatly value the opportunity to reconnect with old friends/colleagues
More informationDEVELOPING PRACTICAL STRATEGIES FOR IMPROVING YOUR CLINICAL TRIAL PARTNERSHIPS TO EXPEDITE DRUG DEVELOPMENT Event Outlook Speaking Faculty
DEVELOPING PRACTICAL STRATEGIES FOR IMPROVING YOUR CLINICAL TRIAL PARTNERSHIPS TO EXPEDITE DRUG DEVELOPMENT Event Outlook BRAND NEW TOPICS FOR A DACH AUDIENCE THE LEADING OUTSOURCING SERIES IN EUROPE NETWORKING
More informationOutsourcing in Clinical Trials Nordics October 30 th 31 st Copenhagen
Outsourcing in Clinical Trials Nordics 2018 October 30 th 31 st Copenhagen 2018 Speakers Confirmed: Magnus Björsne, CEO, AstraZeneca BioVentureHub Mikkel Skovborg, Executive Specialist, NovoNordisk Thomas
More informationAlmac ONE: One Unified Clinical Trial Supply Solution
Almac ONE: One Unified Clinical Trial Supply Solution There is ONE solution to solving the challenges of managing multiple supply chain vendors... Almac ONE - Your ONE Unified Solution Solution has redefined
More informationAbout Preclinical Development Operations Summit
Prioritizing the sourcing and management of preclinical vendors for faster and more successful candidate development About Preclinical Development Operations Summit The Preclinical Development Operations
More informationAbout Arena s Clinical Trial Series Confirmed Speaking Faculty
About Arena s Clinical Trial Series The Clinical Trials Conference series launched over a decade ago and now runs in more than 14 locations worldwide. The acclaimed series is a platform for biopharmaceutical
More informationFebruary 25, 2019 (Monday) 8:30-16:30 Hrs BioPark Visit (Only for Invitees)
February 25, 2019 (Monday) 8:30-16:30 Hrs BioPark Visit (Only for Invitees) 18:00-19:30 Hrs Inauguration of the 16 th BioAsia Convention Presentation of Genome Valley Excellence Award 19:30-20:00 Hrs Inauguration
More informationDEVELOPING CLINICAL TRIALS INFRASTRUCTURE
DEVELOPING CLINICAL TRIALS INFRASTRUCTURE SESSION IV of IOM Workshop: Envisioning a Transformed Clinical Trials Enterprise in the United States: Establishing an Agenda for 2020 PAUL EISENBERG PETRA KAUFMANN
More informationOutsourcing in Clinical Trials Nordics October 30 th 31 st Copenhagen
Outsourcing in Clinical Trials Nordics 2018 October 30 th 31 st Copenhagen 2018 Speakers Confirmed: Magnus Björsne, CEO, AstraZeneca BioVentureHub Mikkel Skovborg, Executive Specialist, NovoNordisk Thomas
More informationTop Challenges with Late Stage Trial Master Files
Top Challenges with Late Stage Trial Master Files The transition from a paper to an electronic Trial Master File (TMF) system is a significant task. In many cases, some pharma and biotech firms (sponsors)
More informationThis is Julius Clinical
This is Julius Clinical WE ARE THE RESEARCH ORGANISATION THAT IS ABLE TO COMBINE THE LATEST SCIENTIFIC INSIGHTS WITH OPERATIONAL EXCELLENCE TO FIND CREDIBLE, CREATIVE, COST-EFFECTIVE SOLUTIONS FOR CLINICAL
More informationMinimising Risk in Clinical Trials. MARSH REPORT July 2017
Minimising Risk in Clinical Trials MARSH REPORT July 2017 CONTENTS 1 Regulatory spotlight on safety and quality in clinical trials 2 Risk mapping in clinical trials Risk identification Risk assessment
More information08:20 Chair s opening remarks Agenda Highlight!
Program Day One 7 th September 2016 07:30 Registration and refreshments 08:20 Chair s opening remarks Agenda Highlight! 08:30 KEYNOTE PRESENTATION Identifying the real meaning of a strategic partnership
More informationV A L U E F R O M A T T E N D I N G S P E A K I N G F A C U L T Y
T E M P E R A T U R E C O N T R O L L E D L O G I S T I C S I N B I O P H A R M A C E U T I C A L S 13 th -14 th March Milan Facilitating a platform for the pharmaceutical industry to refine their temperature
More informationAnalyzing which software needs to be utilized to ensure a timely and more automated process
Clinical Data Integration & Management March 20 th Program Day One 07:30 Registration and refreshments 08:15 Chair s opening remarks Terry Katz, Director, Head of DM and Statistics, Merck Animal Health
More information2018 North American Real-World Evidence Enterprise Solutions Market Leadership Award
2018 North American Real-World Evidence Enterprise Solutions Market Leadership Award 2018 2018 NORTH AMERICAN REAL-WORLD EVIDENCE ENTERPRISE SOLUTIONS MARKET LEADERSHIP AWARD Contents Background and Company
More informationGxP Auditing, Remediation, and Staff Augmentation
GxP Auditing, Remediation, and Staff Augmentation TABLE OF CONTENTS 3 Introduction 4 GxP Auditing 4 GMP Auditing 5 GCP Auditing 6 GLP Auditing 7 Pharmacovigilance Auditing 7 Vendor/Supplier Auditing 8
More information08:20 Chair s opening remarks Agenda Highlight!
Program Day One 7 th September 2016 07:30 Registration and refreshments 08:20 Chair s opening remarks Agenda Highlight! 08:30 KEYNOTE PRESENTATION Identifying the real meaning of a strategic partnership
More informationAn integrated model approach to improve the management of marketed products
Insight brief Regulatory and safety integration An integrated model approach to improve the management of marketed products Leo Dodds, Principal, Quintiles Advisory Services John Rogers, Engagement Leader,
More informationDay 2 Stream. Addressing key operational and outsourcing issues for Israeli biopharma and medical device companies engaged in clinical trials
Day 2 Stream Addressing key operational and outsourcing issues for Israeli biopharma and medical device companies engaged in clinical trials 2016 SPEAKERS INCLUDE; Event Chair Day 1; Dr. Sharon Hashmueli,
More information7 th Annual Clinical Data Integration & Management March 20 th 21 st Princeton, NJ
7 th Annual Clinical Data Integration & Management March 20 th 21 st Princeton, NJ 2018 Speaking faculty Audrey Hill, Senior Director, Data Management, Advaxis Abhijit Parab, Director, Clinical Data Management
More informationAnalyzing which software needs to be utilized to ensure a timely and more automated process
Clinical Data Integration & Management March 20 th Program Day One 08:15 Registration and refreshments 08:50 Chair s opening remarks Analyzing which software needs to be utilized to ensure a timely and
More informationVendor Selection: Identifying Effective Procedures & Strategies
Outsourcing Clinical Trials Canada 15 th November 2012 Vendor Selection: Identifying Effective Procedures & Strategies John S Andrews PhD President and CSO, NeurAxon Inc President, Ketogen Inc CSO, Talon
More informationADP ihcm Supporting Strategy and Execution ADP ihcm Executive Briefing for CEOs
ADP ihcm Supporting Strategy and Execution ADP ihcm Executive Briefing for CEOs The rise of the people-driven strategy Adaptability. Skills. Engagement. Your number one priority is your overall business
More informationGxP Auditing, Remediation, and Staff Augmentation
GxP Auditing, Remediation, and Staff Augmentation TABLE OF CONTENTS 3 Introduction 4 GxP Auditing 4 GMP Auditing 5 GCP Auditing 5 GLP Auditing 6 Pharmacovigilance Auditing 6 Vendor/Supplier Auditing 7
More informationOutsourcing in Clinical Trials Southern California 2018 September 26 th 27 th La Jolla
Outsourcing in Clinical Trials Southern California 2018 September 26 th 27 th La Jolla This year s conference has a solid range of emergent topics, a variety of subject matter expert speakers and excellent
More information9th European Quality Conference Guidelines for submission of Potential Case Studies
9th European Quality Conference Guidelines for submission of Potential Case Studies 15-16 May 2017 Hilton Malta Joining forces and breaking silos towards a better performing, transparent and inclusive
More informationVeeva 2018 Unified Clinical Operations Survey
PRELIMINARY FINDINGS Veeva 2018 Unified Clinical Operations Survey The Veeva 2018 Unified Clinical Operations Survey examines the life sciences industry s progress toward a unified clinical environment
More informationArena International s Inaugural Outsourcing in Clinical Trials Southern California, La Jolla.
Arena International s Inaugural Outsourcing in Clinical Trials Southern California, La Jolla. Program Day One September 24 th 2013 07:45 08:20 Registration and refreshments Chair s opening remarks Sarah
More informationHow to rescue a clinical trial
How to rescue a clinical trial Clinical trial conduct is demanding and rigorous, especially in orphan indications where patient populations are small. Even well-qualified, specifically selected Contract
More informationScience Strategy
Science Strategy 2017-2019 September 2017 Food Safety Authority of Ireland Science Strategy, 2017-2019 CONTENTS EXECUTIVE SUMMARY 1 THE FSAI SCIENCE STRATEGY 2 SPECIFIC ACTIVITIES TO ACHIEVE THE STRATEGIC
More informationWelcome. Thank you for joining us. Irina Moissiu, Director Client Relations Laurie Furiness, EVP Operations & Consulting Services
Welcome Thank you for joining us Irina Moissiu, Director Client Relations Laurie Furiness, EVP Operations & Consulting Services 360 o SERVICE PERFORMANCE MEASUREMENT Sponsor View TM 5 Assessments Available
More information1201 Maryland Avenue SW, Suite 900, Washington, DC ,
1201 Maryland Avenue SW, Suite 900, Washington, DC 20024 202-962-9200, www.bio.org May 31, 2012 Dockets Management Branch (HFA-305) Food and Drug Administration 5600 Fishers Lane, Rm. 1061 Rockville, MD
More informationCRO Outlook 2015: A Paperless Path to a Competitive Advantage
CRO Outlook 2015: A Paperless Path to a Competitive Advantage Dec 22, 2014 By Jennifer Goldsmith Applied Clinical Trials All signs indicate that 2015 should be another good year for contract research organizations
More informationRegulatory business process services: A strategic enabler
Regulatory business process services: A strategic enabler Achieving cost containment and regulatory savvy through partnership Life sciences companies are under enormous cost and resource pressure. According
More informationWhile individually rare, orphan diseases are actually collectively common, with an OF ORPHAN DRUG DEVELOPMENT MEETING THE UNIQUE CHALLENGES
ELECTRONICALLY REPRINTED FROM JUNE 2017 CLINICAL TRIALS Rare Diseases: MEETING THE UNIQUE CHALLENGES OF ORPHAN DRUG DEVELOPMENT BY MICHAEL F. MURPHY, MD, Ph D While individually rare, orphan diseases are
More informationV A L U E F R O M A T T E N D I N G S P E A K I N G F A C U L T Y
T E M P E R A T U R E C O N T R O L L E D L O G I S T I C S I N B I O P H A R M A C E U T I C A L S 13 th -14 th March Milan Facilitating a platform for the pharmaceutical industry to refine their temperature
More informationOutsourcing in Clinical Trials Southern California 2018 September 26 th 27 th La Jolla
Outsourcing in Clinical Trials Southern California 2018 September 26 th 27 th La Jolla This year s conference has a solid range of emergent topics, a variety of subject matter expert speakers and excellent
More informationADP ihcm Rethink Human Capital Management
ADP ihcm Rethink Human Capital Management Invest in engagement Today s workforce is more and more guided by a search for meaning or doing important work, rather than by simply earning a paycheck with good
More informationMulti-Stakeholder Collaborations Can Minimize Barriers & Drive Rare Disease Clinical Programs to Better Patient Outcomes
WHITE PAPER Multi-Stakeholder Collaborations Can Minimize Barriers & Drive Rare Disease Clinical Programs to Better Patient Outcomes Author: SCOTT SCHLIEBNER Vice President, Rare Disease - Scientific Affairs
More informationBOARD PAPER - NHS ENGLAND. Title: Developing commissioning support the future for commissioning support units
Paper: 011404 BOARD PAPER - NHS ENGLAND Title: Developing commissioning support the future for commissioning support units Clearance: Rosamond Roughton, Interim National Director: Commissioning Development
More informationExtract of Non-Paper for discussion with TSG Members. Performance Development Framework Vision for the Customs and Taxation Profession ( )
Extract of Non-Paper for discussion with TSG Members Performance Development Framework Vision for the Customs and Taxation Profession (2016-2020) Approved by : Name 0.0 version : Name Date: 30/03/2015
More informationUNIVERSAL ACTIVITY NUMBERS
SC #20 Real World Evidence Studies to Evaluate the Safety and Effectiveness of Therapeutic Interventions Is the Data Fit for Purpose and How Will You Know? 0286-0000-18-500-L04-P SC #21 The IDMP Challenge:
More informationENHANCING CLINICAL DATA QUALITY WITH SPECIALIZED FUNCTIONAL SERVICE PROVIDER MODEL
Shaping the Future of Drug Development ENHANCING CLINICAL DATA QUALITY WITH SPECIALIZED FUNCTIONAL SERVICE PROVIDER MODEL Jim Baker Senior Vice President Clinical Research Services Cytel JIM BAKER Senior
More informationVeeva 2017 Unified Clinical Operations Survey
PRELIMINARY FINDINGS Veeva 2017 Unified Clinical Operations Survey The Veeva 2017 Unified Clinical Operations Survey examines the life sciences industry s progress toward a unified clinical environment
More informationABPI response to European Commission consultation on advanced therapy medicinal products
ABPI response to European Commission consultation on advanced therapy medicinal products 28 March 2013 ABPI response to European Commission consultation on the regulation of advanced therapy medicinal
More informationReturn of Results Aggregate and Individual
Return of Results Aggregate and Individual Jessica Scott, MD, JD Head of R&D Patient Engagement, Takeda David Leventhal Senior Director Clinical Innovation, Pfizer March 18, 2019 Disclaimer The views and
More informationBOARD PAPER - NHS ENGLAND. Purpose of Paper: To inform the Board of the development of an NHS England Personalised Medicine Strategy.
Paper: PB.24.09.15/05 Title: Personalised Medicine Strategy. From: Sir Bruce Keogh, National Medical Director. BOARD PAPER - NHS ENGLAND Purpose of Paper: To inform the Board of the development of an NHS
More informationRecommendations for Strengthening the Investigator Site Community
Recommendations for Strengthening the Investigator Site Community October 2017 CTTI MISSION: To develop and drive adoption of practices that will increase the quality and efficiency of clinical trials
More informationConfirmed speakers for 2018 include:
Returning for its 5 th year, the Spirits Strategies & Innovation Congress is taking place on the 30-31 st October in London. For the first time, the conference will combine strategies with innovation,
More informationMEDICAL DEVICES PROGRAMME
MEDICAL DEVICES PROGRAMME 3-4 October 2017 Medical Devices Symposium, updated 29August 2017, external Page 1 Working Party Margareth Jorvid LSM Group, Sweden (Chair) Michael Kipping MHRA, UK Janine Jamieson
More informationSupporting and applying research in the NHS. 1. Overview
Supporting and applying research in the NHS 1. Overview Improving commercial research set-up Recap of ongoing activities NHS England and the National Institute for Health Research (NIHR) have published
More informationThe business landscape 2017/18. An Experian research report
The business landscape 2017/18 An Experian research report Contents. It really is a data powered future 3 The business landscape is changing rapidly Top priorities our research identified Data analytics
More informationWhere BioPharma stakeholders
Where BioPharma stakeholders meet to do business in Korea www.terrapinn.com/biopharma-korea BIOPHARMA KOREA The BioPharma series happens around the world in Mexico, Asia (Singapore), India and now Korea!
More informationGxP Auditing, Remediation, and Quality System Resourcing
GxP Auditing, Remediation, and Quality System Resourcing TABLE OF CONTENTS 3 Introduction 4 GxP Auditing 4 GMP Auditing 5 GCP Auditing 6 GLP Auditing 7 Pharmacovigilance Auditing 7 Vendor/Supplier Auditing
More informationBoosting clinical trial activity in the Nordics
Conference Name: 5 th Annual Outsourcing in Clinical Trials Nordics Conference location: Crowne Plaza Copenhagen Towers, Copenhagen, Denmark Conference Programme Day One: 10 th October 08:15 Registration
More informationEHR4CR DEPLOYING INNOVATIVE CLINICAL TRIAL SERVICES. Brecht Claerhout, Custodix NV on behalf of the EHR4CR Consortium
EHR4CR DEPLOYING INNOVATIVE CLINICAL TRIAL SERVICES Brecht Claerhout, Custodix NV on behalf of the EHR4CR Consortium Electronic Health Records for Clinical Research Re-use of EHR data for optimizing Clinical
More informationCRO partner in Rx/CDx Co-Development
CRO partner in Rx/CDx Co-Development DEDICATED DIALOGUE A sponsored roundtable discussion published in Pharmaceutical Executive Two Covance executives discuss a CRO s role in supporting Companion Diagnostics
More informationGDPR. Are you ready for the GDPR countdown?
Are you ready for the countdown? SOLUTIONS LOOK TO THE FUTURE There s more to than just compliance; find out how to use the new regulation as a springboard to unlocking greater business value from your
More information2015 PHARMACEUTICAL MARKET ACCESS IN CHINA SUMMIT
2015 PHARMACEUTICAL MARKET ACCESS IN CHINA SUMMIT September 24 th, 2015 Beijing, China Hear Critical Regulatory Update from Previous & Priority Inviting Keynote Speakers China Food & Drug Administration
More informationWorking together to achieve shared goals in product packaging and labelling
Working together to achieve shared goals in product packaging and labelling New for 2018 In follow up to the 10 year anniversary of the flagship Pharma Packaging and Labelling East Coast event in February
More informationNodes and the Pharmaceutical Industry. Apps in Healthcare
Nodes and the Pharmaceutical Industry Apps in Healthcare Pharma Companies as Drivers for Digital Healthcare New means and expectations The digital revolution presents an opportunity to build an entirely
More informationPosition Paper. Executive Summary
Position Paper Status: Final Date of document: 10.10.2017 Hospital Exemption for Advanced Therapy Medicinal Products (ATMPs): greater transparency needed in order to improve patient safety and access to
More informationWorking together to achieve shared goals in product packaging and labeling
Working together to achieve shared goals in product packaging and labeling Following on from our 10th anniversary edition Pharma Packaging and Labeling will be returning to Philadelphia for its 11th edition.
More informationYour 2019 speaker faculty includes:
Your 2019 speaker faculty includes: Paul Thomas, Global Head of Insights, Asahi Claire Cogan, Head of Insight & Category Marketing, Britvic Ireland Upma Vermani, Senior Manager, Consumer Insights, Analytics
More informationJob description and person specification
Job description and person specification Position Job title Head of Genomics Unit Directorate Finance, Commercial and Specialised Commissioning Pay band AFC Band 9 Responsible to Director of Strategy and
More information9.30am-10.05am am-10.50am. Keynote Session. Issue-based Session. Case Study
Keynote Session Issue-based Session Case Study Product Demonstration Interactive Discussion Public Sector Focus Supply Chain Futures (Sustainability Focus) 9.30am-10.05am eworld Purchasing & Supply Opening
More informationBelgium, a European leader in clinical trials
Belgium, a European leader in clinical trials An attractive country for clinical trials to test innovative medicines In Europe it is nearly impossible to find other countries with as many clinical trials
More informationInnovate Reconciliation Action Plan
Innovate Reconciliation Action Plan Australian Press Council March 2017 March 2019 Message from Press Council Chair I am absolutely delighted that Reconciliation Australia has approved the Press Council
More informationSMARTER DRUG DEVELOPMENT: TRANSFORMING YOUR CLINICAL OPERATING MODEL
SMARTER DRUG DEVELOPMENT: TRANSFORMING YOUR CLINICAL OPERATING MODEL Perspective WHY NOW? THE URGENCY TO CHANGE THE CLINICAL OPERATING MODEL While today is an exciting time for the biopharma industry in
More informationOutsourcing in Clinical Trials Southern California 2018 September 26 th 27 th La Jolla
Outsourcing in Clinical Trials Southern California 2018 September 26 th 27 th La Jolla This year s conference has a solid range of emergent topics, a variety of subject matter expert speakers and excellent
More informationThe Role of the CRO in Effective Risk-Based Monitoring
New Whitepaper The Role of the CRO in Effective Risk-Based Monitoring The clinical trial industry is evolving. In an effort to improve participant safety and data integrity, regulators are encouraging
More informationCCTG initiative. patient reported outcomes (including wearables)
Executive Summary Canada can be a global leader in the next generation of pharmaceutical and cancer care innovation. The Canadian Cancer Trials Group (CCTG) is requesting $39 million in federal funding
More informationDIGITAL REACH INITIATIVE ROADMAP
DIGITAL REACH INITIATIVE ROADMAP DIGITAL REGIONAL EAST AFRICAN COMMUNITY HEALTH INITIATIVE TOWARDS A REGIONAL COMMITMENT TO IMPROVE HEALTH OUTCOMES THROUGH DIGITAL TECHNOLOGY The Digital REACH Initiative
More informationUnlocking hidden value within regulatory affairs
Unlocking hidden value within regulatory affairs By Denis Berry, Paul Saias, and Brian Williams, KPMG in the U.S. These are chaotic times for life sciences organizations, rife with opportunities and risks.
More informationConnecting with patients. Digital engagement leads the way to stronger relationships
Connecting with patients Digital engagement leads the way to stronger relationships Connecting with patients / Digital engagement leads the way to stronger relationships Executive summary Connecting with
More informationThe Integration of Market Access and Advocacy: The Changing Landscape OCTOBER 2016
The Integration of Market Access and Advocacy: The Changing Landscape OCTOBER 2016 The Integration of Market Access and Advocacy: The Changing Landscape Introduction Healthcare market access and advocacy
More informationAgenda Item 8. Page 31
Agenda Item 8 Proposed Governance Arrangements for Joint Commissioning of Health and Social Care between Lincolnshire County Council, the Four Lincolnshire Clinical Commissioning Groups and the Local Area
More informationDepartment At-A-Glance
Integrated Site Services Functional Role Integrated Site Services (ISS) includes global and country Start-Up and Regulatory units (RSU) and Integrated Patients & Site Services (IPSS). Our department s
More informationInsights into the Evolving Pricing & Market Access Environment
Insights into the Evolving Pricing & Market Access Environment UBC Global Market Access Survey July 2012 JULY 2012 GLOBAL MARKET ACCESS SURVEY UBC s Global Market Access Survey: Setting the Stage For those
More informationEnabling business execution with SuccessFactors delivered by BearingPoint
Enabling business execution with SuccessFactors delivered by BearingPoint Human capital and talent management We help clients to implement human capital management strategies that enable an organisation
More informationOutsourcing in Clinical Trials Nordics 2018 October 30 th 31 st Copenhagen
Outsourcing in Clinical Trials Nordics 2018 October 30 th 31 st Copenhagen 2018 Speakers Confirmed: Magnus Björsne, CEO, AstraZeneca BioVentureHub Mikkel Skovborg, Executive Specialist, NovoNordisk Thomas
More informationA SMALL FISH IN A BIG POND MATCHING THE NEEDS OF SMALLER PHARMA SPONSORS
A SMALL FISH IN A BIG POND MATCHING THE NEEDS OF SMALLER PHARMA SPONSORS WITH THE RIGHT CRO DR SALLY ADAMS DEVELOPMENT DIRECTOR SCANCELL LTD 1 SCANCELL LTD Founded in 1997 as a spin-out from the University
More informationCode of Governance for Community Housing Cymru s Members (a consultation)
Code of Governance for Community Housing Cymru s Members (a consultation) March 2018 Code of Governance for Community Housing Cymru s Members (a consultation) March 2018 About the Code Good governance
More information